HPE vs NBIX · P/E 20, rev $32.19B vs P/E 45, rev $1.77B
Hewlett Packard Enterprise Co (HPE) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
HPE currently screens at market cap $27.19B and trailing P/E 19.9. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the HPE and NBIX stock pages for the full models.
Not investment advice.